OraSure Technologies (OSUR) Stock: Buy, Sell, or Hold?
OSUR - OraSure Technologies Inc
$3.46
-0.48 (-12.31%)
βΌ
5d:
-17.15%
30d:
-12.86%
90d:
-17.15%
WAIT
LOW Confidence
Analysis Updated: Nov 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
5d
Get Alerted When OSUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: OSUR is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: OSUR is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: OSUR is currently trading at $3.46, which is considered extended relative to its 30-day fair value range of $3.74 to $4.05.
Technical Outlook: Technically, OSUR is in a downtrend. The price is currently testing key support at $3.46. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 12.3% recently.
Market Sentiment: OSUR scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.50 (+59.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSUR is in a downtrend. The price is currently testing key support at $3.46. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 12.3% recently.
Market Sentiment: OSUR scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.50 (+59.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.74 -
$4.05
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (21/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-12.3%)
- BULLISH: Trading 59.2% below Wall St target ($5.50)
- WARNING: Composite score 44/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.74 -
$4.05
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.46
Resistance Level
$4.38
Current Trend
Downtrend
Technical data as of
Nov 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.48
Wall Street Target
$5.50
(+59.2%)
Revenue Growth (YoY)
-1.9%
Earnings Growth (YoY)
29.6%
Profit Margin
-43.7%
Share & Embed Analysis
Last updated: November 03, 2026 6:45 AM ET
Data refreshes hourly during market hours. Next update: 7:45 AM
Data refreshes hourly during market hours. Next update: 7:45 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$483 | 36 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$202 | 63 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 25 SELL |
|
WST
West Pharmaceutical Serv⦠|
STRONG BUY
16 analysts |
$445 | 44 HOLD |
|
WRBY
Warby Parker Inc |
STRONG BUY
13 analysts |
$31 | 57 HOLD |